IP Verse

Elend patent opposition analysis

The comprehensive analysis of Elend opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Elend

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP2699248	Method For Preparing A Depleted Plasma Material Consisting Of One Or More Thrombogenic Factors	LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES	Nov 8, 2017	STRAWMAN
EP2404600	Use Of The Combination Of A Sinus Current If Inhibitor And An Inhibitor Of The Angiotensin Conversion Enzyme For Treating Cardiac Insufficiency	LES LABORATOIRES SERVIER	Feb 26, 2016	GENERICS UK
EP1845961	Prevention And Treatment Of Thromboembolic Disorders	BAYER	Jan 21, 2016	GENERICS UK TRADING MYLAN

Top companies who are the clients of Elend